Fingerprint
Dive into the research topics of 'Sequential Use of the Tyrosine Kinase Inhibitors Sorafenib and Sunitinib in Metastatic Renal Cell Carcinoma: A Retrospective Outcome Analysis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically